Actualités et Activités de Deciphera Pharmaceuticals
Présence
ONO Pharmaceutical fait partie des...
ONO Pharmaceutical est une société cotée sous le symbole boursier 4528 (JP).
ONO Pharmaceutical a une présence directe dans 2 pays.
Acquisition, funding and merger involving ONO Pharmaceutical.
Dirigeants
Voir l'organigramme avec ses 13 principaux dirigeants
Biographies les plus recherchées chez Deciphera Pharmaceuticals
- Ryota Udagawa, Chief Executive Officer and President
- Toichi Takino, Director
- Masayuki Tanigawa, Director
Créer une alerte
pour suivre les mouvements de dirigeants chez Deciphera Pharmaceuticals.
Pharmacie
ONO Pharmaceutical a 1 833 concurrents dont Pfizer (Etats—Unis), Sanofi (France) et Eli Lilly (Etats—Unis).
Actualités en fusion/acquisition en Pharmacie.
- Imbria Pharmaceuticals vient d'annoncer une levée de fonds de 58 millions de dollars. (publié le 10 avril 2025).
- Clario a acquis NRx Pharmaceuticals (publié le 18 mars 2025).
- Knight Therapeutics has announced the acquisition of Paladin Labs (publié le 12 mars 2025).
Contacts en Pharmacie
Actualités
Derniers communiqués de presse par Deciphera Pharmaceuticals
- Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2022 Financial Results | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 4, 2022 | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Appoints Kelley Dealhoy as Chief Business Officer | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. to Participate in Upcoming Investor Conferences | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Announces First Quarter 2022 Financial Results | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 4, 2022 | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Pre-funded Warrants | Deciphera Pharmaceuticals, Inc.
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de Deciphera Pharmaceuticals
- Deciphera Pharmaceuticals sur Wikipédia, Google News & Yahoo Finance en 1-click
- Deciphera Pharmaceuticals sur LinkedIn, Twitter & YouTube en 1-click
